Novel thiophenecarboxamide IKK-2 inhibitors

被引:3
|
作者
不详
机构
关键词
asthma; chronic obstructive pulmonary disease (COPD); I kappa B kinase-2 (IKK-2); inflammation; rheumatoid arthritis; thiophene;
D O I
10.1517/13543776.15.3.343
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two applications claim novel ureido 5-(2-aminoethoxyphenyl)thiophenecarboxamide derivatives that differ in the position of the attached alkoxy chain, either ortho or para, as I kappa B kinase-2 (IKK-2) inhibitors. Some of the compounds display low nanomolar potency, and the compounds are claimed to be useful in the treatment of asthma, rheumatoid arthritis and chronic obstructive pulmonary disease (COPD).
引用
收藏
页码:343 / 347
页数:5
相关论文
共 50 条
  • [31] IκB kinase-2independent and -dependent inflammation in airway disease models:: Relevance of IKK-2 inhibition to the clinic
    Birrell, Mark A.
    Wong, Sissie
    Hardaker, Elizabeth L.
    Catley, Matthew C.
    McCluskie, Kerryn
    Collins, Michael
    Haj-Yahia, Saleem
    Belvisi, Maria G.
    MOLECULAR PHARMACOLOGY, 2006, 69 (06) : 1791 - 1800
  • [32] Peptides corresponding to the N and C termini of IκB-α, -β, and -ε as probes of the two catalytic subunits of IκB kinase, IKK-1 and IKK-2
    Burke, JR
    Wood, MK
    Ryseck, RP
    Walther, S
    Meyers, CA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) : 36146 - 36152
  • [33] Kinetic mechanisms of IkB related kinases INK-i and TBK-1 differ from IKK-1/IKK-2 heterodimer.
    Huynh, KQ
    Kishore, N
    Mathialagan, S
    Donnelly, AM
    Tripp, CS
    FASEB JOURNAL, 2002, 16 (05): : A1180 - A1180
  • [34] I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma
    Ayad Al-Katib
    Alan A Arnold
    Amro Aboukameel
    Angela Sosin
    Peter Smith
    Anwar N Mohamed
    Frances W Beck
    Ramzi M Mohammad
    Molecular Cancer, 9
  • [35] I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma
    Al-Katib, Ayad
    Arnold, Alan A.
    Aboukameel, Amro
    Sosin, Angela
    Smith, Peter
    Mohamed, Anwar N.
    Beck, Frances W.
    Mohammad, Ramzi M.
    MOLECULAR CANCER, 2010, 9
  • [36] Development of small molecule inhibitors of IKK2
    Hotchkiss, Sonjiala
    Ghosh, Gourisankar
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [37] Profiling expression of NF-κB signaling target genes in IKK-2 inhibitor treated pterygium and conjunctiva fibroblast cells
    Hou, Aihua
    Tin, Minqi
    Tong, Louis
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [38] p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD
    Banerjee, Audreesh
    Koziol-White, Cynthia
    Panettieri, Reynold, Jr.
    CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (03) : 287 - 292
  • [39] Inhibition of tissue factor by blockade of NFkB and IKK-2 using gene transfer: NFkB as a therapeutic target for reducing plaque thrombogenicity
    Monaco, C
    Andreakos, E
    Kinakidis, S
    Feldmann, M
    Paleolog, E
    EUROPEAN HEART JOURNAL, 2002, 23 : 20 - 20
  • [40] Pharmacophore Modeling and Hybrid Virtual Screening for the Discovery of Novel IκB Kinase 2 (IKK2) Inhibitors
    Xie, Huan-Zhang
    Liu, Ling-Yun
    Ren, Ji-Xia
    Zhou, Jian-Ping
    Zheng, Ren-Lin
    Li, Lin-Li
    Yang, Sheng-Yong
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2011, 29 (01): : 165 - 179